EM

Emerson Electric Co.

EMRIndustrialsNASDAQ

Specialty Industrial Machinery

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$18.02B
+3.0% YoY
Net Income
$2.29B
+16.5% YoY
EBITDA
$4.84B
+20.0% YoY
Free Cash Flow
$3.71B

Scan Results

Daily timeframe
4 recent days hidden. Fresh signals are a Premium featureUpgrade →
DateIndicatorDetails
Oct 20▼ MACD Negative CrossoverHistogram -0.0360, negative momentum
Oct 12▼ RSI OverboughtRSI 70.0, above 70, stock may be overbought
About Emerson Electric Co.

Emerson Electric Co., a technology and software company, provides various solutions in the Americas, Asia, the Middle East, Africa, and Europe. At a $90.57B market cap, Emerson Electric Co. ranks as a large-cap company within industrials. It operates through Final Control, Measurement & Analytical, Discrete Automation, Safety & Productivity, Control Systems & Software, and Test & Measurement segments.

Where EMR stands vs its 150-day and 200-day moving averages

As of the October 20, 2026 close, EMR finished 10.48% above its 150-day moving average ($145.31) and 10.41% above its 200-day moving average ($145.40). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.

Is EMR overbought or oversold?

At the October 20, 2026 close, EMR's RSI(14) was 57.4, in neutral territory (between 30 and 70). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.

Key stats
Market Cap$90.57B
P/E (TTM)35.38
Fwd P/E22.24
EPS$4.57
Beta1.21
52W Change+20.3%
Dividend Yield1.37%
ROE12.8%
Analysis

On the balance sheet, EMR has $2.18B in cash with $13.80B in obligations. The ability to service this debt comfortably depends on continued operational cash generation. Annual free cash flow of $3.71B supports ongoing capital allocation decisions and provides a cushion against unexpected expenses or downturns. Return on equity stands at 12.8%, which is decent for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. An ROA of 6.9% suggests reasonable efficiency in deploying the company's asset base. Revenue has grown from $13.80B (2022) to $18.02B (2025), reflecting a 31% increase over the period.

Debt significantly exceeds cash reserves, which means the company's financial flexibility could be constrained during economic downturns. No single metric tells the full story. Reviewing EMR's risk profile alongside its fundamentals and technical indicators provides a more complete picture.

Links
More Industrials stocks
Browse all stocks →
⚠Not financial advice. Scanance shows end-of-day technical indicators (not real-time prices) for information only. Results can be wrong; past performance does not guarantee future results.PrivacyTerms